Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Better Buy? Seattle Genetics or ImmunoGen
Motley Fool
Thursday, March 31, 2011 - 6:59pm
tags:
Immunogen, Seattle Genetics
J&J Loses Bid to Overturn $482 Million Patent Verdict
Bloomberg
Thursday, March 31, 2011 - 6:57pm
tags:
patents, JNJ
Peering Into Pfizer’s Future
Forbes
Thursday, March 31, 2011 - 6:56pm
tags:
Pfizer, generics, Lipitor
Biotech Fever Spreads
Forbes
Thursday, March 31, 2011 - 12:30pm
tags:
biotech, Cephalon, Dendreon, Celgene, Human Genome Sciences
BioSante's Potential Blockbuster Treatment
Seeking Alpha
Thursday, March 31, 2011 - 12:29pm
tags:
BioSante, LibiGel, female sexual dysfunction, Boehringer Ingelheim, Warner Chilcott
Vertex Pharmaceuticals' potential hepatitis C treatment meets safety goal in midstage study
Yahoo/AP
Thursday, March 31, 2011 - 12:27pm
tags:
hepatitis C, Vertex Pharmaceuticals, VX-222
Pharmasset Hepatitis C Drug Combination Helped 98% of Patients
Bloomberg
Thursday, March 31, 2011 - 12:25pm
tags:
hepatitis C, Phamasset, PSI-7977
Valeant's Surprise Bid for Cephalon: Repeating a Growth Trick?
Seeking Alpha
Thursday, March 31, 2011 - 11:56am
tags:
M&A, Cephalon, Valeant Pharmaceuticals
Major FDA Approval Could Pave the Way for These 5 Biotechs
Seeking Alpha
Thursday, March 31, 2011 - 11:55am
tags:
FDA, rindopepimut, brain cancer, Celldex, Geron, AML, GRNVAC1, blinatumomab, Micromet, non-Hodgkin's lymphoma, acute lymphoblastic leukemia, Oncothyreon, Stimuvax, breast cancer, lung cancer, Allovectin-7, Vical, melanoma
Gilead's Long-Term Cancer Fight
Motley Fool
Thursday, March 31, 2011 - 11:51am
tags:
Gilead Sciences, cancer
FDA fast-tracks Nile Therapeutics drug
Bizjournals.com
Thursday, March 31, 2011 - 11:00am
tags:
FDA, fast track, cenderitide, Nile Therapeutics
Insider-Trading Case Puts Focus on Key FDA System
WSJ Online
Thursday, March 31, 2011 - 10:46am
tags:
FDA, insider trading
Valeant may up Cephalon offer if given books
Winnipeg Free Press, Canada
Thursday, March 31, 2011 - 10:45am
tags:
Cephalon, Valeant Pharmaceuticals, M&A
NeurogesX Q4 loss more than doubles
Bizjournals.com
Thursday, March 31, 2011 - 10:43am
tags:
NeurogesX, earnings
Allos Therapeutics Evenly Poised
Yahoo/Zacks.com
Thursday, March 31, 2011 - 10:43am
tags:
Allos, Celgene, Folotyn, T-cell lymphoma
Ahead of the Bell: Analyst lowers Bristol-Myers
Yahoo/AP
Thursday, March 31, 2011 - 10:41am
tags:
Bristol-Myers Squibb, downgrades
Medicare to pay for $93,000 prostate cancer drug Provenge
Yahoo/AP
Thursday, March 31, 2011 - 9:58am
tags:
Medicare, prostate cancer, Dendreon, Provenge
J&J Reorganizes McNeil Consumer Unit After Year of Recalls
Bloomberg
Thursday, March 31, 2011 - 9:58am
tags:
reorganization, recalls, JNJ, McNeil
Pfizer Collaboration With Apple/FDA: A Strategic Shift to Scientific Content in Marketing
Seeking Alpha
Thursday, March 31, 2011 - 9:32am
tags:
Apple/FDA, Pfizer
[video] Momentum BioPharmaceutical Play: Stocks Under $10
TheStreet.com
Thursday, March 31, 2011 - 9:31am
tags:
Cornerstone Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.